Jenny H. Chang, MD, on Neoadjuvant Immunotherapy for Merkel Cell Carcinoma

Posted: Tuesday, April 16, 2024

Jenny H. Chang, MD, of the Cleveland Clinic, discusses her new treatment findings on stage III Merkel cell carcinoma and the potential for adding neoadjuvant immunotherapy to the standard regimen of surgical excision with adjuvant or definitive radiotherapy.

---